Search

• Exposure to PFOS and EtFOSAA affects urea cycle metabolism in maternal serum of pregnant women. • PFOS and EtFOSAA exhibit different association with key amino acid metabolites. • PFOS, but not EtFOSAA, activates energy metabolism pathways. High-resolution metabolomics (HRM) profiling of metabolic fingerprints can improve understanding of how poly and perfluoroalkyl substances (PFASs) induce metabolic alterations of in utero environment and impact fetal health. HRM profiling and quantification of PFASs were performed for 397 maternal perinatal serum samples collected from 1959-1967 in the Child Health and Development Studies (CHDS). We used Metabolome-Wide Association Studies (MWAS) and pathway enrichment analysis for metabolic associations with PFOS, its precursor EtFOSAA, and EtFOSAA-to-PFOS ratio. Distinct metabolic profiles were found with EtFOSAA and PFOS. Urea cycle metabolites such as arginine, lysine and creatine had opposite associations with EtFOSAA (negative) and PFOS (positive); whereas, carnitine shuttle metabolites were found to be exclusively and positively associated with PFOS indicating perturbation in fatty acid metabolism. These differential metabolic associations for precursor and end-product represent an important first step in identifying how PFASs alter the in utero environment and potentially leads to disease risk. [ABSTRACT FROM AUTHOR]

• Maternal exposure to DDT and DDE is associated with changes in metabolome. • Differential metabolic pathways were linked to serum p , p '-DDT and p , p '-DDE levels. • Consistent changes in amino acid metabolism was found in DDT-treated mice. The advancement of high-resolution metabolomics (HRM) and metabolome-wide-association study (MWAS) enables the readout of environmental effects in human specimens. We used HRM to understand DDT-induced alterations of in utero environment and potential health effects. Endogenous metabolites were measured in 397 maternal perinatal serum samples collected during 1959-1967 in the Child Health and Development Studies (CHDS) and in 16 maternal postnatal serum samples of mice treated with or without DDT. MWAS was performed to assess associations between metabolites and p , p '-DDT, o , p '-DDT and p , p '-DDE levels, followed by pathway analysis. Distinct metabolic profiles were found with p , p '-DDT and p , p '-DDE. Amino acids such arginine had a strong association with p , p '-DDT and o , p '-DDT in both women and mice, whereas lipids and acyl-carnitine intermediates were found exclusively associated with p , p '-DDE in CHDS women indicating mitochondrial impairment. It suggests that the role of serine and fatty acid metabolism on the causal disease pathway should be examined. [ABSTRACT FROM AUTHOR]

• Exposure to PFOS and EtFOSAA affects urea cycle metabolism in maternal serum of pregnant women. • PFOS and EtFOSAA exhibit different association with key amino acid metabolites. • PFOS, but not EtFOSAA, activates energy metabolism pathways. High-resolution metabolomics (HRM) profiling of metabolic fingerprints can improve understanding of how poly and perfluoroalkyl substances (PFASs) induce metabolic alterations of in utero environment and impact fetal health. HRM profiling and quantification of PFASs were performed for 397 maternal perinatal serum samples collected from 1959-1967 in the Child Health and Development Studies (CHDS). We used Metabolome-Wide Association Studies (MWAS) and pathway enrichment analysis for metabolic associations with PFOS, its precursor EtFOSAA, and EtFOSAA-to-PFOS ratio. Distinct metabolic profiles were found with EtFOSAA and PFOS. Urea cycle metabolites such as arginine, lysine and creatine had opposite associations with EtFOSAA (negative) and PFOS (positive); whereas, carnitine shuttle metabolites were found to be exclusively and positively associated with PFOS indicating perturbation in fatty acid metabolism. These differential metabolic associations for precursor and end-product represent an important first step in identifying how PFASs alter the in utero environment and potentially leads to disease risk. [ABSTRACT FROM AUTHOR]